BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 12368140)

  • 21. [Lipoprotein(A) distribution among adults and its relation to the incidence of coronary artery disease in Changsha City].
    Li X; Zhao S; Wang Z
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):320-2. PubMed ID: 9868086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].
    Liu X; Sun L; Li Z; Gao Y; Hui R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1396-400. PubMed ID: 12509922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of post-methionine homocysteine and lipoprotein (a) in evaluating the cardiovascular risk in young CAD patients.
    Marcucci R; Brunelli T; Fedi S; Pepe G; Giusti B; Gori AM; Prisco D; Falai M; Margheri M; Abbate R; Gensini GF
    Eur J Clin Invest; 2005 Jan; 35(1):1-7. PubMed ID: 15638812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interaction of ApoE and LDL-R gene polymorphisms and alcohol drinking and smoking on coronary heart disease].
    Wang CH; Zhou X; Zhou GD; Han DF; Zheng F
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):554-8. PubMed ID: 15144588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lp(a), homocysteine and a family history of early ischemic cerebral stroke.
    Torbus-Lisiecka B; Bukowska H; Jastrzebska M; Chelstowski K; Honczarenko K; Naruszewicz M
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11 Suppl 5():52-9. PubMed ID: 12063777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
    Tarkun I; Cetinarslan B; Cantürk Z
    Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):127-31. PubMed ID: 12325469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of serum lipoprotein(a) with the clinical presentation of Thai coronary artery disease patients.
    Leowattana W; Mahanonda N; Bhuripanyo K; Pokum S; Worawattananon P
    J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S194-8. PubMed ID: 11194014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
    Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V
    J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
    Carević V; Rumboldt M; Rumboldt Z;
    Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Waist-hip ratio and low HDL predict the risk of coronary artery disease in Pakistanis.
    Nishtar S; Wierzbicki AS; Lumb PJ; Lambert-Hammill M; Turner CN; Crook MA; Mattu MA; Shahab S; Badar A; Ehsan A; Marber MS; Gill J
    Curr Med Res Opin; 2004 Jan; 20(1):55-62. PubMed ID: 14741073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Homocysteine and coronary events in coronary disease patients].
    Ambrosi P; Barlatier A; Artaud-Navarro A; Habib G; Ferracci A; Boussuges A; Garçon D; Bouvenot G; Luccioni R
    Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):185-9. PubMed ID: 12555379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study on the relationship between Lp(a) and arteriosclerotic cerebral infarction].
    Tan Y; Yao C; Shen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):36-8. PubMed ID: 10322706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between lipoprotein(a) and the complications of diabetes mellitus.
    Koschinsky ML; Marcovina SM
    Acta Diabetol; 2003 Jun; 40(2):65-76. PubMed ID: 12861403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors of Hong Kong Chinese patients with coronary heart disease.
    Chair SY; Lee SF; Lopez V; Ling EM
    J Clin Nurs; 2007 Jul; 16(7):1278-84. PubMed ID: 17584346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is a history of gestational diabetes related to risk factors for coronary heart disease?
    King KB; Gerich JE; Guzick DS; King KU; McDermott MP
    Res Nurs Health; 2009 Jun; 32(3):298-306. PubMed ID: 19274765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein Lp(a) excess and coronary heart disease.
    Stein JH; Rosenson RS
    Arch Intern Med; 1997 Jun; 157(11):1170-6. PubMed ID: 9183227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lp(a) lipoprotein--an independent risk factor for coronary heart disease after menopause.
    Futterman LG; Lemberg L
    Am J Crit Care; 2001 Jan; 10(1):63-7. PubMed ID: 11153187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.